White House Releases 2026 Drug Strategy Focused on Fentanyl Crackdowns, Treatment Targets

Overview

• The White House released its 2026 National Drug Control Strategy on Wednesday, outlining a cross‑agency plan that targets fentanyl networks and expands public‑health responses.
• The strategy sets a goal to raise nationally certified recovery‑ready workplaces from 15 in 2024 to 60 by 2029.
• Officials aim to increase federally funded naloxone kits sent to states from 5.2 million in 2024 to 5.5 million by 2029.
• The plan calls for modernized research and real‑time drug surveillance that can spot new threats faster and help hospitals and state agencies act sooner.
• The rollout follows CDC data showing overdose deaths fell 20.6% in 2025, while STAT reports tensions with recent federal moves that limited support for test strips, warned on medication treatment, and briefly canceled about $2 billion in SAMHSA grants.